OpenURL Connection Search

Select item for more details and to access through your institution.

Trends and Efficacy of Interferon-Free Anti–hepatitis C Virus Therapy in the Region of High Prevalence of Elderly Patients, Cirrhosis, and Hepatocellular Carcinoma: A Real-World, Nationwide, Multicenter Study of 10 688 Patients in Japan.
Published in:
Open Forum Infectious Diseases, 2019, v. 6, n. 5, p. N.PAG, doi. 10.1093/ofid/ofz185
By:
- Toyoda, Hidenori;
- Atsukawa, Masanori;
- Uojima, Haruki;
- Nozaki, Akito;
- Tamai, Hideyuki;
- Takaguchi, Koichi;
- Fujioka, Shinichi;
- Nakamuta, Makoto;
- Tada, Toshifumi;
- Yasuda, Satoshi;
- Chuma, Makoto;
- Senoh, Tomonori;
- Tsutsui, Akemi;
- Yamashita, Naoki;
- Hiraoka, Atsushi;
- Michitaka, Kojiro;
- Shima, Toshihide;
- Akahane, Takehiro;
- Itobayashi, Ei;
- Watanabe, Tsunamasa
Publication type:
Article
C-reactive protein to albumin ratio predicts survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-12058-y
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Shimada, Noritomo;
- Kawata, Kazuhito
Publication type:
Article
Clinical and therapeutic features and prognostic factors of metastatic colorectal cancer over age 80: a retrospective study.
Published in:
2021
By:
- Hisada, Hiroyuki;
- Takahashi, Yu;
- Kubota, Manabu;
- Shimura, Haruhisa;
- Itobayashi, Ei;
- Shimura, Kenji;
- Nakamura, Akira
Publication type:
journal article
Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
Published in:
Cancer Reports, 2024, v. 7, n. 4, p. 1, doi. 10.1002/cnr2.2042
By:
- Ohama, Hideko;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Hatanaka, Takeshi;
- Tani, Joji;
- Takaguchi, Koichi;
- Atsukawa, Masanori;
- Itobayashi, Ei;
- Nishimura, Takashi;
- Tsuji, Kunihiko;
- Tajiri, Kazuto;
- Ishikawa, Toru;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Fukunishi, Shinya;
- Ogawa, Chikara;
- Kakizaki, Satoru;
- Shimada, Noritomo
Publication type:
Article
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience.
Published in:
Cancer Reports, 2022, v. 5, n. 2, p. 1, doi. 10.1002/cnr2.1464
By:
- Atsushi Hiraoka;
- Takashi Kumada;
- Toshifumi Tada;
- Masashi Hirooka;
- Kazuya Kariyama;
- Joji Tani;
- Masanori Atsukawa;
- Koichi Takaguchi;
- Ei Itobayashi;
- Shinya Fukunishi;
- Kunihiko Tsuji;
- Toru Ishikawa;
- Kazuto Tajiri;
- Hironori Ochi;
- Satoshi Yasuda;
- Hidenori Toyoda;
- Chikara Ogawa;
- Takashi Nishimura;
- Takeshi Hatanaka;
- Hideko Ohama
Publication type:
Article
Predictive factors and survival outcome of conversion therapy for unresectable hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: Comparative analysis of conversion, partial response and complete response patients.
Published in:
Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1361, doi. 10.1111/apt.18237
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishikawa, Hiroki;
- Nishimura, Takashi;
- Kawata, Kazuhito;
- Kosaka, Hisashi
Publication type:
Article
Outcomes of patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab in real‐world clinical practice who met or did not meet the inclusion criteria for the phase 3 IMbrave150 trial.
Published in:
Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 233, doi. 10.1111/apt.18037
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Nishikawa, Hiroki;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Koshiyama, Yuichi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Kawata, Kazuhito
Publication type:
Article
Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study).
Published in:
Investigational New Drugs, 2024, v. 42, n. 4, p. 394, doi. 10.1007/s10637-024-01441-3
By:
- Kobayashi, Kazufumi;
- Ogasawara, Sadahisa;
- Itobayashi, Ei;
- Okubo, Tomomi;
- Itokawa, Norio;
- Nakamura, Kazuyoshi;
- Moriguchi, Michihisa;
- Watanabe, Shunji;
- Ikeda, Masafumi;
- Kuroda, Hidekatsu;
- Kawaoka, Tomokazu;
- Hiraoka, Atsushi;
- Yasui, Yutaka;
- Kuzuya, Teiji;
- Sato, Rui;
- Kanzaki, Hiroaki;
- Koroki, Keisuke;
- Inoue, Masanori;
- Nakamura, Masato;
- Kiyono, Soichiro
Publication type:
Article
Sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Japan.
Published in:
Investigational New Drugs, 2020, v. 38, n. 1, p. 172, doi. 10.1007/s10637-019-00801-8
By:
- Ogasawara, Sadahisa;
- Ooka, Yoshihiko;
- Itokawa, Norio;
- Inoue, Masanori;
- Okabe, Shinichiro;
- Seki, Atsuyoshi;
- Haga, Yuki;
- Obu, Masamichi;
- Atsukawa, Masanori;
- Itobayashi, Ei;
- Mizumoto, Hideaki;
- Sugiura, Nobuyuki;
- Azemoto, Ryosaku;
- Kanayama, Kengo;
- Kanzaki, Hiroaki;
- Maruta, Susumu;
- Maeda, Takahiro;
- Kusakabe, Yuko;
- Yokoyama, Masayuki;
- Kobayashi, Kazufumi
Publication type:
Article
Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: Multicenter study.
Published in:
Hepatology Research, 2024, v. 54, n. 4, p. 382, doi. 10.1111/hepr.13991
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Yokohama, Keisuke;
- Nishikawa, Hiroki
Publication type:
Article
Geriatric nutritional risk index as an easy‐to‐use assessment tool for nutritional status in hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Published in:
Hepatology Research, 2023, v. 53, n. 10, p. 1031, doi. 10.1111/hepr.13934
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Association of proton pump inhibitor and antibiotic use with the clinical outcomes of hepatocellular carcinoma patients receiving atezolizumab and bevacizumab: A multicenter analysis.
Published in:
Hepatology Research, 2023, v. 53, n. 8, p. 737, doi. 10.1111/hepr.13905
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Shimada, Noritomo
Publication type:
Article
Carbon‐ion radiotherapy versus radiofrequency ablation as initial treatment for early‐stage hepatocellular carcinoma.
Published in:
Hepatology Research, 2022, v. 52, n. 12, p. 1060, doi. 10.1111/hepr.13827
By:
- Fujita, Naoto;
- Kanogawa, Naoya;
- Makishima, Hirokazu;
- Ogasawara, Sadahisa;
- Maruta, Susumu;
- Iino, Yotaro;
- Shiko, Yuki;
- Kanzaki, Hiroaki;
- Koroki, Keisuke;
- Kobayashi, Kazufumi;
- Kiyono, Soichiro;
- Nakamura, Masato;
- Kondo, Takayuki;
- Nakamoto, Shingo;
- Chiba, Tetsuhiro;
- Wakatsuki, Masaru;
- Itobayashi, Ei;
- Obu, Masamichi;
- Koma, Yoshihiro;
- Azemoto, Ryosaku
Publication type:
Article
Validation of the easy‐to‐use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib.
Published in:
Hepatology Research, 2022, v. 52, n. 12, p. 1050, doi. 10.1111/hepr.13824
By:
- Rimini, Margherita;
- Kang, Wonseok;
- Burgio, Valentina;
- Persano, Mara;
- Aoki, Tamoko;
- Shimose, Shigeo;
- Tada, Toshifumi;
- Kumada, Takashi;
- Sho, Takuya;
- Lai, Eleonora;
- Celsa, Ciro;
- Campani, Claudia;
- Tonnini, Matteo;
- Tamburini, Emiliano;
- Hiraoka, Atsushi;
- Takaguchi, Koichi;
- Nishida, Naoshi;
- Iwamoto, Hideki;
- Itobayashi, Ei;
- Tsuji, Kunihiko
Publication type:
Article
Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice.
Published in:
Hepatology Research, 2022, v. 52, n. 9, p. 773, doi. 10.1111/hepr.13797
By:
- Tanaka, Takaaki;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Association of early bevacizumab interruption with efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: A landmark analysis.
Published in:
Hepatology Research, 2022, v. 52, n. 5, p. 462, doi. 10.1111/hepr.13748
By:
- Hatanaka, Takeshi;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Kakizaki, Satoru;
- Shimada, Noritomo
Publication type:
Article
Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC‐B stage patients classified as beyond up to seven criteria – Multicenter analysis.
Published in:
Hepatology Research, 2022, v. 52, n. 3, p. 308, doi. 10.1111/hepr.13734
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Therapeutic efficacy of lenvatinib as third‐line treatment after regorafenib for unresectable hepatocellular carcinoma progression.
Published in:
Hepatology Research, 2021, v. 51, n. 8, p. 880, doi. 10.1111/hepr.13644
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Hatanaka, Takeshi;
- Tada, Toshifumi;
- Kariyama, Kazuya;
- Tani, Joji;
- Fukunishi, Shinya;
- Atsukawa, Masanori;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Tajiri, Kazuto;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ochi, Hironori;
- Kawata, Kazuhito;
- Yasuda, Satoshi;
- Toyoda, Hidenori
Publication type:
Article
Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis.
Published in:
Hepatology Research, 2021, v. 51, n. 2, p. 201, doi. 10.1111/hepr.13592
By:
- Chuma, Makoto;
- Uojima, Haruki;
- Hiraoka, Atsushi;
- Kobayashi, Satoshi;
- Toyoda, Hidenori;
- Tada, Toshifumi;
- Hidaka, Hisashi;
- Iwabuchi, Shogo;
- Numata, Kazushi;
- Itobayashi, Ei;
- Itokawa, Norio;
- Kariyama, Kazuya;
- Ohama, Hideko;
- Hattori, Nobuhiro;
- Hirose, Shunji;
- Shibata, Hiroshi;
- Tani, Joji;
- Imai, Michitaka;
- Tajiri, Kazuto;
- Moriya, Satoshi
Publication type:
Article
Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matching.
Published in:
Hepatology Research, 2020, v. 50, n. 1, p. 75, doi. 10.1111/hepr.13427
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Michitaka, Kojiro;
- Atsukawa, Masanori;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Kariyama, Kazuya;
- Itobayashi, Ei;
- Tajiri, Kazuto;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ochi, Hironori;
- Toyoda, Hidenori;
- Nouso, Kazuhiro;
- Tsutsui, Akemi;
- Nagano, Takuya;
- Itokawa, Norio
Publication type:
Article
Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysis.
Published in:
Hepatology Research, 2019, v. 49, n. 1, p. 111, doi. 10.1111/hepr.13243
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Kariyama, Kazuya;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Shimada, Noritomo;
- Tajiri, Kazuto;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Ochi, Hironori;
- Hirooka, Masashi;
- Tsutsui, Akemi;
- Shibata, Hiroshi;
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Nouso, Kazuhiro;
- Joko, Kouji;
- Hiasa, Yoichi;
- Michitaka, Kojiro
Publication type:
Article
A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin–bilirubin grade.
Published in:
Hepatology Research, 2018, v. 48, n. 3, p. E61, doi. 10.1111/hepr.12927
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Itobayashi, Ei;
- Kariyama, Kazuya;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hirofumi;
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Nouso, Kazuhiro;
- Joko, Koji;
- Kawasaki, Hideki;
- Hiasa, Yoichi;
- Michitaka, Kojiro;
- On Behalf Of The Real‐life Practice Experts For Hcc (relpec) Study Group And Hcc 48 Group (hepatocellular Carcinoma Experts From 48 Clinics)
Publication type:
Article
Characteristics and prognosis of hepatocellular carcinoma detected in patients with chronic hepatitis C after the eradication of hepatitis C virus: A multicenter study from Japan.
Published in:
Hepatology Research, 2016, v. 46, n. 8, p. 734, doi. 10.1111/hepr.12613
By:
- Toyoda, Hidenori;
- Tada, Toshifumi;
- Tsuji, Kunihiko;
- Hiraoka, Atsushi;
- Tachi, Yoshihiko;
- Itobayashi, Ei;
- Takaguchi, Koichi;
- Senoh, Tomonori;
- Takizawa, Daichi;
- Ishikawa, Toru;
- Kumada, Takashi
Publication type:
Article
Is there a survival benefit in interventional radiology for hepatocellular carcinoma in patients with Child-Pugh C liver cirrhosis?: A multicenter study.
Published in:
Hepatology Research, 2016, v. 46, n. 6, p. 521, doi. 10.1111/hepr.12583
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Michitaka, Kojiro;
- Toyoda, Hidenori;
- Tada, Toshifumi;
- Ishikawa, Toru;
- Itobayashi, Ei;
- Shimada, Noritomo;
- Takaguchi, Koichi;
- Takizawa, Daichi;
- Tsuji, Kunihiko
Publication type:
Article
Usefulness of Tumor Marker Score for Predicting the Prognosis of Hepatocellular Carcinoma Patients Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study.
Published in:
Cancers, 2023, v. 15, n. 17, p. 4348, doi. 10.3390/cancers15174348
By:
- Tanaka, Kazunari;
- Tsuji, Kunihiko;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Shimada, Noritomo
Publication type:
Article
Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma.
Published in:
Cancers, 2019, v. 11, n. 2, p. 203, doi. 10.3390/cancers11020203
By:
- Kariyama, Kazuya;
- Nouso, Kazuhiro;
- Toyoda, Hidenori;
- Tada, Toshifumi;
- Hiraoka, Atsushi;
- Tsuji, Kunihiko;
- Itobayashi, Ei;
- Ishikawa, Toru;
- Wakuta, Akiko;
- Oonishi, Ayano;
- Kumada, Takashi;
- Kudo, Masatoshi
Publication type:
Article
Comparison of prognostic impact of atezolizumab plus bevacizumab versus lenvatinib in patients with intermediate‐stage hepatocellular carcinoma.
Published in:
Liver International, 2024, v. 44, n. 1, p. 113, doi. 10.1111/liv.15753
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Neutrophil‐to‐lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib.
Published in:
Liver International, 2020, v. 40, n. 4, p. 968, doi. 10.1111/liv.14405
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Michitaka, Kojiro;
- Atsukawa, Masanori;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Kariyama, Kazuya;
- Itobayashi, Ei;
- Tajiri, Kazuto;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Fukunishi, Shinya;
- Ohama, Hideko;
- Kawata, Kazuhito
Publication type:
Article
Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment Modality.
Published in:
Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 565, doi. 10.1159/000530078
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Kariyama, Kazuya;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Naganuma, Atsushi;
- Itobayashi, Ei;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Ohama, Hideko;
- Tada, Fujimasa;
- Nouso, Kazuhiro
Publication type:
Article
Relationship of Atezolizumab plus Bevacizumab Treatment with Muscle Volume Loss in Unresectable Hepatocellular Carcinoma Patients: Multicenter Analysis.
Published in:
Liver Cancer (2235-1795), 2023, v. 12, n. 3, p. 209, doi. 10.1159/000527402
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma.
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 473, doi. 10.1159/000515552
By:
- Koroki, Keisuke;
- Kanogawa, Naoya;
- Maruta, Susumu;
- Ogasawara, Sadahisa;
- Iino, Yotaro;
- Obu, Masamichi;
- Okubo, Tomomi;
- Itokawa, Norio;
- Maeda, Takahiro;
- Inoue, Masanori;
- Haga, Yuki;
- Seki, Atsuyoshi;
- Okabe, Shinichiro;
- Koma, Yoshihiro;
- Azemoto, Ryosaku;
- Atsukawa, Masanori;
- Itobayashi, Ei;
- Ito, Kenji;
- Sugiura, Nobuyuki;
- Mizumoto, Hideaki
Publication type:
Article
Posttreatment after Lenvatinib in Patients with Advanced Hepatocellular Carcinoma.
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 473, doi. 10.1159/000515552
By:
- Koroki, Keisuke;
- Kanogawa, Naoya;
- Maruta, Susumu;
- Ogasawara, Sadahisa;
- Iino, Yotaro;
- Obu, Masamichi;
- Okubo, Tomomi;
- Itokawa, Norio;
- Maeda, Takahiro;
- Inoue, Masanori;
- Haga, Yuki;
- Seki, Atsuyoshi;
- Okabe, Shinichiro;
- Koma, Yoshihiro;
- Azemoto, Ryosaku;
- Atsukawa, Masanori;
- Itobayashi, Ei;
- Ito, Kenji;
- Sugiura, Nobuyuki;
- Mizumoto, Hideaki
Publication type:
Article
What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355
By:
- Atsushi Hiraoka;
- Takashi Kumada;
- Toshifumi Tada;
- Kazuya Kariyama;
- Joji Tani;
- Shinya Fukunishi;
- Masanori Atsukawa;
- Masashi Hirooka;
- Kunihiko Tsuji;
- Toru Ishikawa;
- Koichi Takaguchi;
- Ei Itobayashi;
- Kazuto Tajiri;
- Noritomo Shimada;
- Hiroshi Shibata;
- Hironori Ochi;
- Kazuhito Kawata;
- Satoshi Yasuda;
- Hidenori Toyoda;
- Hideko Ohama
Publication type:
Article
EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis.
Published in:
Liver Cancer (2235-1795), 2020, v. 9, n. 6, p. 734, doi. 10.1159/000508971
By:
- Kariyama, Kazuya;
- Nouso, Kazuhiro;
- Hiraoka, Atsushi;
- Wakuta, Akiko;
- Oonishi, Ayano;
- Kuzuya, Teiji;
- Toyoda, Hidenori;
- Tada, Toshifumi;
- Tsuji, Kunihiko;
- Itobayashi, Ei;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Tsutsui, Akemi;
- Shimada, Noritomo;
- Kudo, Masatoshi;
- Kumada, Takashi
Publication type:
Article
Potential of Lenvatinib for an Expanded Indication from the REFLECT Trial in Patients with Advanced Hepatocellular Carcinoma.
Published in:
Liver Cancer (2235-1795), 2020, v. 9, n. 4, p. 382, doi. 10.1159/000507022
By:
- Maruta, Susumu;
- Ogasawara, Sadahisa;
- Ooka, Yoshihiko;
- Obu, Masamichi;
- Inoue, Masanori;
- Itokawa, Norio;
- Haga, Yuki;
- Seki, Atsuyoshi;
- Okabe, Shinichiro;
- Azemoto, Ryosaku;
- Itobayashi, Ei;
- Atsukawa, Masanori;
- Sugiura, Nobuyuki;
- Mizumoto, Hideaki;
- Koroki, Keisuke;
- Kanayama, Kengo;
- Kanzaki, Hiroaki;
- Kobayashi, Kazufumi;
- Kiyono, Soichiro;
- Nakamura, Masato
Publication type:
Article
Comparing the impact of atezolizumab plus bevacizumab and lenvatinib on the liver function in hepatocellular carcinoma patients: A mixed‐effects regression model approach.
Published in:
Cancer Medicine, 2023, v. 12, n. 24, p. 21680, doi. 10.1002/cam4.6726
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Yokohama, Keisuke;
- Nishikawa, Hiroki
Publication type:
Article
Effect of butyrate‐producing enterobacteria on advanced hepatocellular carcinoma treatment with atezolizumab and bevacizumab.
Published in:
Cancer Medicine, 2023, v. 12, n. 17, p. 17849, doi. 10.1002/cam4.6416
By:
- Nouso, Kazuhiro;
- Shiota, Shohei;
- Fujita, Rio;
- Wakuta, Akiko;
- Kariyama, Kazuya;
- Hiraoka, Atsushi;
- Atsukawa, Masanori;
- Tani, Joji;
- Tada, Toshifumi;
- Nakamura, Shinichiro;
- Tajiri, Kazuto;
- Kaibori, Masaki;
- Hirooka, Masashi;
- Itobayashi, Ei;
- Kakizaki, Satoru;
- Naganuma, Atsushi;
- Ishikawa, Toru;
- Hatanaka, Takeshi;
- Fukunishi, Shinya;
- Tsuji, Kunihiko
Publication type:
Article
Adverse events as potential predictive factors of therapeutic activity in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Published in:
Cancer Medicine, 2023, v. 12, n. 7, p. 7772, doi. 10.1002/cam4.5535
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
New prognostic system based on inflammation and liver function predicts prognosis in patients with advanced unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: A validation study.
Published in:
Cancer Medicine, 2023, v. 12, n. 6, p. 6980, doi. 10.1002/cam4.5495
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Kariyama, Kazuya;
- Tani, Joji;
- Hirooka, Masashi;
- Takaguchi, Koichi;
- Atsukawa, Masanori;
- Fukunishi, Shinya;
- Itobayashi, Ei;
- Tsuji, Kunihiko;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Ishikawa, Toru;
- Yasuda, Satoshi;
- Ogawa, Chikara;
- Toyoda, Hidenori;
- Hatanaka, Takeshi;
- Nishimura, Takashi;
- Kakizaki, Satoru
Publication type:
Article
Comparative efficacy and safety of atezolizumab and bevacizumab between hepatocellular carcinoma patients with viral and non‐viral infection: A Japanese multicenter observational study.
Published in:
Cancer Medicine, 2023, v. 12, n. 5, p. 5293, doi. 10.1002/cam4.5337
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Shimada, Noritomo
Publication type:
Article
The hepatocellular carcinoma modified Gustave Roussy Immune score (HCC‐GRIm score) as a novel prognostic score for patients treated with atezolizumab and bevacizumab: A multicenter retrospective analysis.
Published in:
Cancer Medicine, 2023, v. 12, n. 4, p. 4259, doi. 10.1002/cam4.5294
By:
- Hatanaka, Takeshi;
- Naganuma, Atsushi;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Shimada, Noritomo
Publication type:
Article
The prognosis of elderly patients with hepatocellular carcinoma: A multi‐center 19‐year experience in Japan.
Published in:
Cancer Medicine, 2023, v. 12, n. 1, p. 345, doi. 10.1002/cam4.4850
By:
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Hiraoka, Atsushi;
- Kariyama, Kazuya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Toyoda, Hidenori;
- Yasuda, Satoshi;
- Naganuma, Atsushi;
- Tada, Toshifumi;
- Takaguchi, Koichi;
- Tsutsui, Akemi;
- Itobayashi, Ei;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Tanaka, Takaaki;
- Nagano, Takuya;
- Imai, Michitaka;
- Nakamura, Shinichiro;
- Nouso, Kazuhiro
Publication type:
Article
Does first‐line treatment have prognostic impact for unresectable HCC?—Atezolizumab plus bevacizumab versus lenvatinib.
Published in:
Cancer Medicine, 2023, v. 12, n. 1, p. 325, doi. 10.1002/cam4.4854
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Tada, Toshifumi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma: A multicenter analysis.
Published in:
Cancer Medicine, 2022, v. 11, n. 20, p. 3796, doi. 10.1002/cam4.4763
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis.
Published in:
Cancer Medicine, 2019, v. 8, n. 8, p. 3719, doi. 10.1002/cam4.2241
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Atsukawa, Masanori;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Kariyama, Kazuya;
- Itobayashi, Ei;
- Tajiri, Kazuto;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ochi, Hironori;
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Nouso, Kazuhiro;
- Tsutsui, Akemi;
- Nagano, Takuya;
- Itokawa, Norio;
- Hayama, Korenobu
Publication type:
Article
Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis.
Published in:
Cancer Medicine, 2019, v. 8, n. 1, p. 137, doi. 10.1002/cam4.1909
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Kariyama, Kazuya;
- Takaguchi, Koichi;
- Atsukawa, Masanori;
- Itobayashi, Ei;
- Tsuji, Kunihiko;
- Tajiri, Kazuto;
- Hirooka, Masashi;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ishikawa, Toru;
- Ochi, Hironori;
- Tada, Toshifumi;
- Toyoda, Hidenori;
- Nouso, Kazuhiro;
- Tsutsui, Akemi;
- Itokawa, Norio;
- Imai, Michitaka;
- Joko, Kouji
Publication type:
Article
Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct‐acting antiviral agents.
Published in:
Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 7, p. 1394, doi. 10.1111/jgh.16553
By:
- Ohama, Hideko;
- Hiraoka, Atsushi;
- Tada, Toshifumi;
- Kariyama, Kazuya;
- Itobayashi, Ei;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Toyoda, Hidenori;
- Hatanaka, Takeshi;
- Kakizaki, Satoru;
- Naganuma, Atsushi;
- Tada, Fujimasa;
- Tanaka, Hironori;
- Nakamura, Shinichiro;
- Nouso, Kazuhiro;
- Tanaka, Kazunari;
- Kumada, Takashi
Publication type:
Article
Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma.
Published in:
Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 5, p. 949, doi. 10.1111/jgh.16494
By:
- Toyoda, Hidenori;
- Tada, Toshifumi;
- Uojima, Haruki;
- Nozaki, Akito;
- Chuma, Makoto;
- Takaguchi, Koichi;
- Hiraoka, Atsushi;
- Abe, Hiroshi;
- Itobayashi, Ei;
- Matsuura, Kentaro;
- Atsukawa, Masanori;
- Watanabe, Tsunamasa;
- Shimada, Noritomo;
- Nakamuta, Makoto;
- Kojima, Motoyuki;
- Tsuji, Kunihiko;
- Mikami, Shigeru;
- Ishikawa, Toru;
- Yasuda, Satoshi;
- Tsutsui, Akemi
Publication type:
Article
Impact of first‐line systemic therapy with atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.
Published in:
Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 8, p. 1389, doi. 10.1111/jgh.16225
By:
- Tada, Toshifumi;
- Kumada, Takashi;
- Hiraoka, Atsushi;
- Hirooka, Masashi;
- Kariyama, Kazuya;
- Tani, Joji;
- Atsukawa, Masanori;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Fukunishi, Shinya;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Tajiri, Kazuto;
- Ochi, Hironori;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ogawa, Chikara;
- Nishimura, Takashi;
- Hatanaka, Takeshi;
- Kakizaki, Satoru
Publication type:
Article
Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting.
Published in:
Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 7, p. 1812, doi. 10.1111/jgh.15336
By:
- Hiraoka, Atsushi;
- Kumada, Takashi;
- Kariyama, Kazuya;
- Tada, Toshifumi;
- Tani, Joji;
- Fukunishi, Shinya;
- Atsukawa, Masanori;
- Hirooka, Masashi;
- Tsuji, Kunihiko;
- Ishikawa, Toru;
- Takaguchi, Koichi;
- Itobayashi, Ei;
- Tajiri, Kazuto;
- Shimada, Noritomo;
- Shibata, Hiroshi;
- Ochi, Hironori;
- Kawata, Kazuhito;
- Yasuda, Satoshi;
- Toyoda, Hidenori;
- Ohama, Hideko
Publication type:
Article

Found: 70